Global Cell-free Tumor DNA Detection Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called 'liquid biopsy'. ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.
LPI (LP Information)' newest research report, the “Cell-free Tumor DNA Detection Industry Forecast” looks at past sales and reviews total world Cell-free Tumor DNA Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell-free Tumor DNA Detection sales for 2023 through 2029. With Cell-free Tumor DNA Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell-free Tumor DNA Detection industry.
This Insight Report provides a comprehensive analysis of the global Cell-free Tumor DNA Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell-free Tumor DNA Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell-free Tumor DNA Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell-free Tumor DNA Detection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell-free Tumor DNA Detection.
The global Cell-free Tumor DNA Detection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell-free Tumor DNA Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell-free Tumor DNA Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell-free Tumor DNA Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell-free Tumor DNA Detection players cover Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, NeoGenomics Laboratories Inc., Menarini Silicon Biosystems and Illumina Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell-free Tumor DNA Detection market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called 'liquid biopsy'. ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.
LPI (LP Information)' newest research report, the “Cell-free Tumor DNA Detection Industry Forecast” looks at past sales and reviews total world Cell-free Tumor DNA Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell-free Tumor DNA Detection sales for 2023 through 2029. With Cell-free Tumor DNA Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell-free Tumor DNA Detection industry.
This Insight Report provides a comprehensive analysis of the global Cell-free Tumor DNA Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell-free Tumor DNA Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell-free Tumor DNA Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell-free Tumor DNA Detection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell-free Tumor DNA Detection.
The global Cell-free Tumor DNA Detection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell-free Tumor DNA Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell-free Tumor DNA Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell-free Tumor DNA Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell-free Tumor DNA Detection players cover Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, NeoGenomics Laboratories Inc., Menarini Silicon Biosystems and Illumina Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell-free Tumor DNA Detection market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Droplet Digital Polymerase Chain Reaction
- Tagged-Amplicon Deep Sequencing
- Others
- Breast Cancer
- Stomach Cancer
- Liver Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biocept Inc.
- Bio-Rad Laboratories Inc.
- Fluxion Biosciences Inc.
- F. Hoffmann-La Roche AG
- Sysmex Europe SE
- Qiagen
- NeoGenomics Laboratories Inc.
- Menarini Silicon Biosystems
- Illumina Inc.
- Guardant Health Inc.
- Shanghai Biotecan Medical Diagnostics Co.,Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell-free Tumor DNA Detection Market Size 2018-2029
2.1.2 Cell-free Tumor DNA Detection Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell-free Tumor DNA Detection Segment by Type
2.2.1 Droplet Digital Polymerase Chain Reaction
2.2.2 Tagged-Amplicon Deep Sequencing
2.2.3 Others
2.3 Cell-free Tumor DNA Detection Market Size by Type
2.3.1 Cell-free Tumor DNA Detection Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
2.4 Cell-free Tumor DNA Detection Segment by Application
2.4.1 Breast Cancer
2.4.2 Stomach Cancer
2.4.3 Liver Cancer
2.4.4 Other
2.5 Cell-free Tumor DNA Detection Market Size by Application
2.5.1 Cell-free Tumor DNA Detection Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
3 CELL-FREE TUMOR DNA DETECTION MARKET SIZE BY PLAYER
3.1 Cell-free Tumor DNA Detection Market Size Market Share by Players
3.1.1 Global Cell-free Tumor DNA Detection Revenue by Players (2018-2023)
3.1.2 Global Cell-free Tumor DNA Detection Revenue Market Share by Players (2018-2023)
3.2 Global Cell-free Tumor DNA Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL-FREE TUMOR DNA DETECTION BY REGIONS
4.1 Cell-free Tumor DNA Detection Market Size by Regions (2018-2023)
4.2 Americas Cell-free Tumor DNA Detection Market Size Growth (2018-2023)
4.3 APAC Cell-free Tumor DNA Detection Market Size Growth (2018-2023)
4.4 Europe Cell-free Tumor DNA Detection Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell-free Tumor DNA Detection Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell-free Tumor DNA Detection Market Size by Country (2018-2023)
5.2 Americas Cell-free Tumor DNA Detection Market Size by Type (2018-2023)
5.3 Americas Cell-free Tumor DNA Detection Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell-free Tumor DNA Detection Market Size by Region (2018-2023)
6.2 APAC Cell-free Tumor DNA Detection Market Size by Type (2018-2023)
6.3 APAC Cell-free Tumor DNA Detection Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell-free Tumor DNA Detection by Country (2018-2023)
7.2 Europe Cell-free Tumor DNA Detection Market Size by Type (2018-2023)
7.3 Europe Cell-free Tumor DNA Detection Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell-free Tumor DNA Detection by Region (2018-2023)
8.2 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL-FREE TUMOR DNA DETECTION MARKET FORECAST
10.1 Global Cell-free Tumor DNA Detection Forecast by Regions (2024-2029)
10.1.1 Global Cell-free Tumor DNA Detection Forecast by Regions (2024-2029)
10.1.2 Americas Cell-free Tumor DNA Detection Forecast
10.1.3 APAC Cell-free Tumor DNA Detection Forecast
10.1.4 Europe Cell-free Tumor DNA Detection Forecast
10.1.5 Middle East & Africa Cell-free Tumor DNA Detection Forecast
10.2 Americas Cell-free Tumor DNA Detection Forecast by Country (2024-2029)
10.2.1 United States Cell-free Tumor DNA Detection Market Forecast
10.2.2 Canada Cell-free Tumor DNA Detection Market Forecast
10.2.3 Mexico Cell-free Tumor DNA Detection Market Forecast
10.2.4 Brazil Cell-free Tumor DNA Detection Market Forecast
10.3 APAC Cell-free Tumor DNA Detection Forecast by Region (2024-2029)
10.3.1 China Cell-free Tumor DNA Detection Market Forecast
10.3.2 Japan Cell-free Tumor DNA Detection Market Forecast
10.3.3 Korea Cell-free Tumor DNA Detection Market Forecast
10.3.4 Southeast Asia Cell-free Tumor DNA Detection Market Forecast
10.3.5 India Cell-free Tumor DNA Detection Market Forecast
10.3.6 Australia Cell-free Tumor DNA Detection Market Forecast
10.4 Europe Cell-free Tumor DNA Detection Forecast by Country (2024-2029)
10.4.1 Germany Cell-free Tumor DNA Detection Market Forecast
10.4.2 France Cell-free Tumor DNA Detection Market Forecast
10.4.3 UK Cell-free Tumor DNA Detection Market Forecast
10.4.4 Italy Cell-free Tumor DNA Detection Market Forecast
10.4.5 Russia Cell-free Tumor DNA Detection Market Forecast
10.5 Middle East & Africa Cell-free Tumor DNA Detection Forecast by Region (2024-2029)
10.5.1 Egypt Cell-free Tumor DNA Detection Market Forecast
10.5.2 South Africa Cell-free Tumor DNA Detection Market Forecast
10.5.3 Israel Cell-free Tumor DNA Detection Market Forecast
10.5.4 Turkey Cell-free Tumor DNA Detection Market Forecast
10.5.5 GCC Countries Cell-free Tumor DNA Detection Market Forecast
10.6 Global Cell-free Tumor DNA Detection Forecast by Type (2024-2029)
10.7 Global Cell-free Tumor DNA Detection Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biocept Inc.
11.1.1 Biocept Inc. Company Information
11.1.2 Biocept Inc. Cell-free Tumor DNA Detection Product Offered
11.1.3 Biocept Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biocept Inc. Main Business Overview
11.1.5 Biocept Inc. Latest Developments
11.2 Bio-Rad Laboratories Inc.
11.2.1 Bio-Rad Laboratories Inc. Company Information
11.2.2 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Offered
11.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bio-Rad Laboratories Inc. Main Business Overview
11.2.5 Bio-Rad Laboratories Inc. Latest Developments
11.3 Fluxion Biosciences Inc.
11.3.1 Fluxion Biosciences Inc. Company Information
11.3.2 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Offered
11.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Fluxion Biosciences Inc. Main Business Overview
11.3.5 Fluxion Biosciences Inc. Latest Developments
11.4 F. Hoffmann-La Roche AG
11.4.1 F. Hoffmann-La Roche AG Company Information
11.4.2 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Offered
11.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 F. Hoffmann-La Roche AG Main Business Overview
11.4.5 F. Hoffmann-La Roche AG Latest Developments
11.5 Sysmex Europe SE
11.5.1 Sysmex Europe SE Company Information
11.5.2 Sysmex Europe SE Cell-free Tumor DNA Detection Product Offered
11.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sysmex Europe SE Main Business Overview
11.5.5 Sysmex Europe SE Latest Developments
11.6 Qiagen
11.6.1 Qiagen Company Information
11.6.2 Qiagen Cell-free Tumor DNA Detection Product Offered
11.6.3 Qiagen Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Qiagen Main Business Overview
11.6.5 Qiagen Latest Developments
11.7 NeoGenomics Laboratories Inc.
11.7.1 NeoGenomics Laboratories Inc. Company Information
11.7.2 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Offered
11.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NeoGenomics Laboratories Inc. Main Business Overview
11.7.5 NeoGenomics Laboratories Inc. Latest Developments
11.8 Menarini Silicon Biosystems
11.8.1 Menarini Silicon Biosystems Company Information
11.8.2 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Offered
11.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Menarini Silicon Biosystems Main Business Overview
11.8.5 Menarini Silicon Biosystems Latest Developments
11.9 Illumina Inc.
11.9.1 Illumina Inc. Company Information
11.9.2 Illumina Inc. Cell-free Tumor DNA Detection Product Offered
11.9.3 Illumina Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Illumina Inc. Main Business Overview
11.9.5 Illumina Inc. Latest Developments
11.10 Guardant Health Inc.
11.10.1 Guardant Health Inc. Company Information
11.10.2 Guardant Health Inc. Cell-free Tumor DNA Detection Product Offered
11.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Guardant Health Inc. Main Business Overview
11.10.5 Guardant Health Inc. Latest Developments
11.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
11.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Company Information
11.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Offered
11.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Main Business Overview
11.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell-free Tumor DNA Detection Market Size 2018-2029
2.1.2 Cell-free Tumor DNA Detection Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell-free Tumor DNA Detection Segment by Type
2.2.1 Droplet Digital Polymerase Chain Reaction
2.2.2 Tagged-Amplicon Deep Sequencing
2.2.3 Others
2.3 Cell-free Tumor DNA Detection Market Size by Type
2.3.1 Cell-free Tumor DNA Detection Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
2.4 Cell-free Tumor DNA Detection Segment by Application
2.4.1 Breast Cancer
2.4.2 Stomach Cancer
2.4.3 Liver Cancer
2.4.4 Other
2.5 Cell-free Tumor DNA Detection Market Size by Application
2.5.1 Cell-free Tumor DNA Detection Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
3 CELL-FREE TUMOR DNA DETECTION MARKET SIZE BY PLAYER
3.1 Cell-free Tumor DNA Detection Market Size Market Share by Players
3.1.1 Global Cell-free Tumor DNA Detection Revenue by Players (2018-2023)
3.1.2 Global Cell-free Tumor DNA Detection Revenue Market Share by Players (2018-2023)
3.2 Global Cell-free Tumor DNA Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL-FREE TUMOR DNA DETECTION BY REGIONS
4.1 Cell-free Tumor DNA Detection Market Size by Regions (2018-2023)
4.2 Americas Cell-free Tumor DNA Detection Market Size Growth (2018-2023)
4.3 APAC Cell-free Tumor DNA Detection Market Size Growth (2018-2023)
4.4 Europe Cell-free Tumor DNA Detection Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell-free Tumor DNA Detection Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell-free Tumor DNA Detection Market Size by Country (2018-2023)
5.2 Americas Cell-free Tumor DNA Detection Market Size by Type (2018-2023)
5.3 Americas Cell-free Tumor DNA Detection Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell-free Tumor DNA Detection Market Size by Region (2018-2023)
6.2 APAC Cell-free Tumor DNA Detection Market Size by Type (2018-2023)
6.3 APAC Cell-free Tumor DNA Detection Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell-free Tumor DNA Detection by Country (2018-2023)
7.2 Europe Cell-free Tumor DNA Detection Market Size by Type (2018-2023)
7.3 Europe Cell-free Tumor DNA Detection Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell-free Tumor DNA Detection by Region (2018-2023)
8.2 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL-FREE TUMOR DNA DETECTION MARKET FORECAST
10.1 Global Cell-free Tumor DNA Detection Forecast by Regions (2024-2029)
10.1.1 Global Cell-free Tumor DNA Detection Forecast by Regions (2024-2029)
10.1.2 Americas Cell-free Tumor DNA Detection Forecast
10.1.3 APAC Cell-free Tumor DNA Detection Forecast
10.1.4 Europe Cell-free Tumor DNA Detection Forecast
10.1.5 Middle East & Africa Cell-free Tumor DNA Detection Forecast
10.2 Americas Cell-free Tumor DNA Detection Forecast by Country (2024-2029)
10.2.1 United States Cell-free Tumor DNA Detection Market Forecast
10.2.2 Canada Cell-free Tumor DNA Detection Market Forecast
10.2.3 Mexico Cell-free Tumor DNA Detection Market Forecast
10.2.4 Brazil Cell-free Tumor DNA Detection Market Forecast
10.3 APAC Cell-free Tumor DNA Detection Forecast by Region (2024-2029)
10.3.1 China Cell-free Tumor DNA Detection Market Forecast
10.3.2 Japan Cell-free Tumor DNA Detection Market Forecast
10.3.3 Korea Cell-free Tumor DNA Detection Market Forecast
10.3.4 Southeast Asia Cell-free Tumor DNA Detection Market Forecast
10.3.5 India Cell-free Tumor DNA Detection Market Forecast
10.3.6 Australia Cell-free Tumor DNA Detection Market Forecast
10.4 Europe Cell-free Tumor DNA Detection Forecast by Country (2024-2029)
10.4.1 Germany Cell-free Tumor DNA Detection Market Forecast
10.4.2 France Cell-free Tumor DNA Detection Market Forecast
10.4.3 UK Cell-free Tumor DNA Detection Market Forecast
10.4.4 Italy Cell-free Tumor DNA Detection Market Forecast
10.4.5 Russia Cell-free Tumor DNA Detection Market Forecast
10.5 Middle East & Africa Cell-free Tumor DNA Detection Forecast by Region (2024-2029)
10.5.1 Egypt Cell-free Tumor DNA Detection Market Forecast
10.5.2 South Africa Cell-free Tumor DNA Detection Market Forecast
10.5.3 Israel Cell-free Tumor DNA Detection Market Forecast
10.5.4 Turkey Cell-free Tumor DNA Detection Market Forecast
10.5.5 GCC Countries Cell-free Tumor DNA Detection Market Forecast
10.6 Global Cell-free Tumor DNA Detection Forecast by Type (2024-2029)
10.7 Global Cell-free Tumor DNA Detection Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biocept Inc.
11.1.1 Biocept Inc. Company Information
11.1.2 Biocept Inc. Cell-free Tumor DNA Detection Product Offered
11.1.3 Biocept Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biocept Inc. Main Business Overview
11.1.5 Biocept Inc. Latest Developments
11.2 Bio-Rad Laboratories Inc.
11.2.1 Bio-Rad Laboratories Inc. Company Information
11.2.2 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Offered
11.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bio-Rad Laboratories Inc. Main Business Overview
11.2.5 Bio-Rad Laboratories Inc. Latest Developments
11.3 Fluxion Biosciences Inc.
11.3.1 Fluxion Biosciences Inc. Company Information
11.3.2 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Offered
11.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Fluxion Biosciences Inc. Main Business Overview
11.3.5 Fluxion Biosciences Inc. Latest Developments
11.4 F. Hoffmann-La Roche AG
11.4.1 F. Hoffmann-La Roche AG Company Information
11.4.2 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Offered
11.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 F. Hoffmann-La Roche AG Main Business Overview
11.4.5 F. Hoffmann-La Roche AG Latest Developments
11.5 Sysmex Europe SE
11.5.1 Sysmex Europe SE Company Information
11.5.2 Sysmex Europe SE Cell-free Tumor DNA Detection Product Offered
11.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sysmex Europe SE Main Business Overview
11.5.5 Sysmex Europe SE Latest Developments
11.6 Qiagen
11.6.1 Qiagen Company Information
11.6.2 Qiagen Cell-free Tumor DNA Detection Product Offered
11.6.3 Qiagen Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Qiagen Main Business Overview
11.6.5 Qiagen Latest Developments
11.7 NeoGenomics Laboratories Inc.
11.7.1 NeoGenomics Laboratories Inc. Company Information
11.7.2 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Offered
11.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NeoGenomics Laboratories Inc. Main Business Overview
11.7.5 NeoGenomics Laboratories Inc. Latest Developments
11.8 Menarini Silicon Biosystems
11.8.1 Menarini Silicon Biosystems Company Information
11.8.2 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Offered
11.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Menarini Silicon Biosystems Main Business Overview
11.8.5 Menarini Silicon Biosystems Latest Developments
11.9 Illumina Inc.
11.9.1 Illumina Inc. Company Information
11.9.2 Illumina Inc. Cell-free Tumor DNA Detection Product Offered
11.9.3 Illumina Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Illumina Inc. Main Business Overview
11.9.5 Illumina Inc. Latest Developments
11.10 Guardant Health Inc.
11.10.1 Guardant Health Inc. Company Information
11.10.2 Guardant Health Inc. Cell-free Tumor DNA Detection Product Offered
11.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Guardant Health Inc. Main Business Overview
11.10.5 Guardant Health Inc. Latest Developments
11.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
11.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Company Information
11.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Offered
11.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Main Business Overview
11.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell-free Tumor DNA Detection Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Droplet Digital Polymerase Chain Reaction
Table 3. Major Players of Tagged-Amplicon Deep Sequencing
Table 4. Major Players of Others
Table 5. Cell-free Tumor DNA Detection Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 8. Cell-free Tumor DNA Detection Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 11. Global Cell-free Tumor DNA Detection Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cell-free Tumor DNA Detection Revenue Market Share by Player (2018-2023)
Table 13. Cell-free Tumor DNA Detection Key Players Head office and Products Offered
Table 14. Cell-free Tumor DNA Detection Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell-free Tumor DNA Detection Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cell-free Tumor DNA Detection Market Size Market Share by Regions (2018-2023)
Table 19. Global Cell-free Tumor DNA Detection Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cell-free Tumor DNA Detection Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cell-free Tumor DNA Detection Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cell-free Tumor DNA Detection Market Size Market Share by Country (2018-2023)
Table 23. Americas Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 25. Americas Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 27. APAC Cell-free Tumor DNA Detection Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cell-free Tumor DNA Detection Market Size Market Share by Region (2018-2023)
Table 29. APAC Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 31. APAC Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 33. Europe Cell-free Tumor DNA Detection Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cell-free Tumor DNA Detection Market Size Market Share by Country (2018-2023)
Table 35. Europe Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 37. Europe Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cell-free Tumor DNA Detection Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cell-free Tumor DNA Detection
Table 46. Key Market Challenges & Risks of Cell-free Tumor DNA Detection
Table 47. Key Industry Trends of Cell-free Tumor DNA Detection
Table 48. Global Cell-free Tumor DNA Detection Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cell-free Tumor DNA Detection Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cell-free Tumor DNA Detection Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cell-free Tumor DNA Detection Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Biocept Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 53. Biocept Inc. Cell-free Tumor DNA Detection Product Offered
Table 54. Biocept Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Biocept Inc. Main Business
Table 56. Biocept Inc. Latest Developments
Table 57. Bio-Rad Laboratories Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 58. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Offered
Table 59. Bio-Rad Laboratories Inc. Main Business
Table 60. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Bio-Rad Laboratories Inc. Latest Developments
Table 62. Fluxion Biosciences Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 63. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Offered
Table 64. Fluxion Biosciences Inc. Main Business
Table 65. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Fluxion Biosciences Inc. Latest Developments
Table 67. F. Hoffmann-La Roche AG Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 68. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Offered
Table 69. F. Hoffmann-La Roche AG Main Business
Table 70. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. F. Hoffmann-La Roche AG Latest Developments
Table 72. Sysmex Europe SE Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 73. Sysmex Europe SE Cell-free Tumor DNA Detection Product Offered
Table 74. Sysmex Europe SE Main Business
Table 75. Sysmex Europe SE Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Sysmex Europe SE Latest Developments
Table 77. Qiagen Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 78. Qiagen Cell-free Tumor DNA Detection Product Offered
Table 79. Qiagen Main Business
Table 80. Qiagen Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Qiagen Latest Developments
Table 82. NeoGenomics Laboratories Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 83. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Offered
Table 84. NeoGenomics Laboratories Inc. Main Business
Table 85. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. NeoGenomics Laboratories Inc. Latest Developments
Table 87. Menarini Silicon Biosystems Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 88. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Offered
Table 89. Menarini Silicon Biosystems Main Business
Table 90. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Menarini Silicon Biosystems Latest Developments
Table 92. Illumina Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 93. Illumina Inc. Cell-free Tumor DNA Detection Product Offered
Table 94. Illumina Inc. Main Business
Table 95. Illumina Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Illumina Inc. Latest Developments
Table 97. Guardant Health Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 98. Guardant Health Inc. Cell-free Tumor DNA Detection Product Offered
Table 99. Guardant Health Inc. Main Business
Table 100. Guardant Health Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Guardant Health Inc. Latest Developments
Table 102. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 103. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Offered
Table 104. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Main Business
Table 106. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Latest Developments
Table 1. Cell-free Tumor DNA Detection Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Droplet Digital Polymerase Chain Reaction
Table 3. Major Players of Tagged-Amplicon Deep Sequencing
Table 4. Major Players of Others
Table 5. Cell-free Tumor DNA Detection Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 8. Cell-free Tumor DNA Detection Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 11. Global Cell-free Tumor DNA Detection Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cell-free Tumor DNA Detection Revenue Market Share by Player (2018-2023)
Table 13. Cell-free Tumor DNA Detection Key Players Head office and Products Offered
Table 14. Cell-free Tumor DNA Detection Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell-free Tumor DNA Detection Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cell-free Tumor DNA Detection Market Size Market Share by Regions (2018-2023)
Table 19. Global Cell-free Tumor DNA Detection Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cell-free Tumor DNA Detection Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cell-free Tumor DNA Detection Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cell-free Tumor DNA Detection Market Size Market Share by Country (2018-2023)
Table 23. Americas Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 25. Americas Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 27. APAC Cell-free Tumor DNA Detection Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cell-free Tumor DNA Detection Market Size Market Share by Region (2018-2023)
Table 29. APAC Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 31. APAC Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 33. Europe Cell-free Tumor DNA Detection Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cell-free Tumor DNA Detection Market Size Market Share by Country (2018-2023)
Table 35. Europe Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 37. Europe Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cell-free Tumor DNA Detection Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cell-free Tumor DNA Detection Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cell-free Tumor DNA Detection Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cell-free Tumor DNA Detection
Table 46. Key Market Challenges & Risks of Cell-free Tumor DNA Detection
Table 47. Key Industry Trends of Cell-free Tumor DNA Detection
Table 48. Global Cell-free Tumor DNA Detection Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cell-free Tumor DNA Detection Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cell-free Tumor DNA Detection Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cell-free Tumor DNA Detection Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Biocept Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 53. Biocept Inc. Cell-free Tumor DNA Detection Product Offered
Table 54. Biocept Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Biocept Inc. Main Business
Table 56. Biocept Inc. Latest Developments
Table 57. Bio-Rad Laboratories Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 58. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Offered
Table 59. Bio-Rad Laboratories Inc. Main Business
Table 60. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Bio-Rad Laboratories Inc. Latest Developments
Table 62. Fluxion Biosciences Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 63. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Offered
Table 64. Fluxion Biosciences Inc. Main Business
Table 65. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Fluxion Biosciences Inc. Latest Developments
Table 67. F. Hoffmann-La Roche AG Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 68. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Offered
Table 69. F. Hoffmann-La Roche AG Main Business
Table 70. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. F. Hoffmann-La Roche AG Latest Developments
Table 72. Sysmex Europe SE Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 73. Sysmex Europe SE Cell-free Tumor DNA Detection Product Offered
Table 74. Sysmex Europe SE Main Business
Table 75. Sysmex Europe SE Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Sysmex Europe SE Latest Developments
Table 77. Qiagen Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 78. Qiagen Cell-free Tumor DNA Detection Product Offered
Table 79. Qiagen Main Business
Table 80. Qiagen Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Qiagen Latest Developments
Table 82. NeoGenomics Laboratories Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 83. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Offered
Table 84. NeoGenomics Laboratories Inc. Main Business
Table 85. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. NeoGenomics Laboratories Inc. Latest Developments
Table 87. Menarini Silicon Biosystems Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 88. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Offered
Table 89. Menarini Silicon Biosystems Main Business
Table 90. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Menarini Silicon Biosystems Latest Developments
Table 92. Illumina Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 93. Illumina Inc. Cell-free Tumor DNA Detection Product Offered
Table 94. Illumina Inc. Main Business
Table 95. Illumina Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Illumina Inc. Latest Developments
Table 97. Guardant Health Inc. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 98. Guardant Health Inc. Cell-free Tumor DNA Detection Product Offered
Table 99. Guardant Health Inc. Main Business
Table 100. Guardant Health Inc. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Guardant Health Inc. Latest Developments
Table 102. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Details, Company Type, Cell-free Tumor DNA Detection Area Served and Its Competitors
Table 103. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Offered
Table 104. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Main Business
Table 106. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Cell-free Tumor DNA Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell-free Tumor DNA Detection Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell-free Tumor DNA Detection Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell-free Tumor DNA Detection Sales Market Share by Country/Region (2022)
Figure 8. Cell-free Tumor DNA Detection Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell-free Tumor DNA Detection Market Size Market Share by Type in 2022
Figure 10. Cell-free Tumor DNA Detection in Breast Cancer
Figure 11. Global Cell-free Tumor DNA Detection Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 12. Cell-free Tumor DNA Detection in Stomach Cancer
Figure 13. Global Cell-free Tumor DNA Detection Market: Stomach Cancer (2018-2023) & ($ Millions)
Figure 14. Cell-free Tumor DNA Detection in Liver Cancer
Figure 15. Global Cell-free Tumor DNA Detection Market: Liver Cancer (2018-2023) & ($ Millions)
Figure 16. Cell-free Tumor DNA Detection in Other
Figure 17. Global Cell-free Tumor DNA Detection Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Cell-free Tumor DNA Detection Market Size Market Share by Application in 2022
Figure 19. Global Cell-free Tumor DNA Detection Revenue Market Share by Player in 2022
Figure 20. Global Cell-free Tumor DNA Detection Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Cell-free Tumor DNA Detection Market Size 2018-2023 ($ Millions)
Figure 22. APAC Cell-free Tumor DNA Detection Market Size 2018-2023 ($ Millions)
Figure 23. Europe Cell-free Tumor DNA Detection Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Cell-free Tumor DNA Detection Market Size 2018-2023 ($ Millions)
Figure 25. Americas Cell-free Tumor DNA Detection Value Market Share by Country in 2022
Figure 26. United States Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Cell-free Tumor DNA Detection Market Size Market Share by Region in 2022
Figure 31. APAC Cell-free Tumor DNA Detection Market Size Market Share by Type in 2022
Figure 32. APAC Cell-free Tumor DNA Detection Market Size Market Share by Application in 2022
Figure 33. China Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Cell-free Tumor DNA Detection Market Size Market Share by Country in 2022
Figure 40. Europe Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Figure 41. Europe Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Figure 42. Germany Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 56. APAC Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 57. Europe Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 59. United States Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 60. Canada Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 63. China Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 64. Japan Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 65. Korea Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 67. India Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 68. Australia Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 69. Germany Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 70. France Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 71. UK Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 72. Italy Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 73. Russia Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 74. Spain Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 77. Israel Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 80. Global Cell-free Tumor DNA Detection Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Cell-free Tumor DNA Detection Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Cell-free Tumor DNA Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell-free Tumor DNA Detection Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell-free Tumor DNA Detection Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell-free Tumor DNA Detection Sales Market Share by Country/Region (2022)
Figure 8. Cell-free Tumor DNA Detection Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell-free Tumor DNA Detection Market Size Market Share by Type in 2022
Figure 10. Cell-free Tumor DNA Detection in Breast Cancer
Figure 11. Global Cell-free Tumor DNA Detection Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 12. Cell-free Tumor DNA Detection in Stomach Cancer
Figure 13. Global Cell-free Tumor DNA Detection Market: Stomach Cancer (2018-2023) & ($ Millions)
Figure 14. Cell-free Tumor DNA Detection in Liver Cancer
Figure 15. Global Cell-free Tumor DNA Detection Market: Liver Cancer (2018-2023) & ($ Millions)
Figure 16. Cell-free Tumor DNA Detection in Other
Figure 17. Global Cell-free Tumor DNA Detection Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Cell-free Tumor DNA Detection Market Size Market Share by Application in 2022
Figure 19. Global Cell-free Tumor DNA Detection Revenue Market Share by Player in 2022
Figure 20. Global Cell-free Tumor DNA Detection Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Cell-free Tumor DNA Detection Market Size 2018-2023 ($ Millions)
Figure 22. APAC Cell-free Tumor DNA Detection Market Size 2018-2023 ($ Millions)
Figure 23. Europe Cell-free Tumor DNA Detection Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Cell-free Tumor DNA Detection Market Size 2018-2023 ($ Millions)
Figure 25. Americas Cell-free Tumor DNA Detection Value Market Share by Country in 2022
Figure 26. United States Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Cell-free Tumor DNA Detection Market Size Market Share by Region in 2022
Figure 31. APAC Cell-free Tumor DNA Detection Market Size Market Share by Type in 2022
Figure 32. APAC Cell-free Tumor DNA Detection Market Size Market Share by Application in 2022
Figure 33. China Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Cell-free Tumor DNA Detection Market Size Market Share by Country in 2022
Figure 40. Europe Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Figure 41. Europe Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Figure 42. Germany Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Cell-free Tumor DNA Detection Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Cell-free Tumor DNA Detection Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 56. APAC Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 57. Europe Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 59. United States Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 60. Canada Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 63. China Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 64. Japan Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 65. Korea Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 67. India Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 68. Australia Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 69. Germany Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 70. France Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 71. UK Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 72. Italy Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 73. Russia Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 74. Spain Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 77. Israel Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Cell-free Tumor DNA Detection Market Size 2024-2029 ($ Millions)
Figure 80. Global Cell-free Tumor DNA Detection Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Cell-free Tumor DNA Detection Market Size Market Share Forecast by Application (2024-2029)
